A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Relapsing Multiple Sclerosis
Related studies linked through entity extraction aliases.
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf
- Status
- COMPLETED
- Phase
- N/A
A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Characterizing the Use of Ofatumumab in a Real World Setting
- Status
- COMPLETED
- Phase
- N/A
Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- N/A
Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran
- Status
- COMPLETED
- Phase
- N/A
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE4
A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE4
A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4